ExecPay

Christine L. Chung

Overview202120202019

Overview

Christine L. Chung received an average of $4M in total compensation, including $470K in salary, at FibroGen from 2019 to 2021.

Source: SEC filings on April 28, 2022 and April 23, 2020.
Chung's 2021 pay

Related executives

We found ten more executives who work or worked at FibroGen.

Enrique Conterno

FibroGen

Chief Executive Officer

2

Mark Eisner

FibroGen

Chief Medical Officer

2

Pat Cotroneo

FibroGen

Chief Financial Officer

9

Elias Kouchakji

FibroGen

Senior Vice President, Clinical Development, Drug Safety, and Pharmacovigilance

3

Thane Wettig

FibroGen

Chief Commercial Officer

2

Juan Graham

FibroGen

Chief Financial Officer

1

K Yu

FibroGen

Chief Medical Officer

8

James Schoeneck

FibroGen

Chief Executive Officer

2

News

You may also like

FibroGen